- Home
- INTS vs CISO Comparison
INTS vs CISO Comparison
Compare INTS & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- CISO
- Stock Information
- Founded
- INTS 2012
- CISO 2015
- Country
- INTS United States
- CISO United States
- Employees
- INTS N/A
- CISO N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- CISO Computer Software: Prepackaged Software
- Sector
- INTS Health Care
- CISO Technology
- Exchange
- INTS Nasdaq
- CISO Nasdaq
- Market Cap
- INTS 35.3M
- CISO 12.4M
- IPO Year
- INTS 2023
- CISO N/A
- Fundamental
- Price
- INTS $2.33
- CISO $1.09
- Analyst Decision
- INTS Strong Buy
- CISO
- Analyst Count
- INTS 3
- CISO 0
- Target Price
- INTS $8.50
- CISO N/A
- AVG Volume (30 Days)
- INTS 18.1K
- CISO 401.5K
- Earning Date
- INTS 03-21-2025
- CISO 04-15-2025
- Dividend Yield
- INTS N/A
- CISO N/A
- EPS Growth
- INTS N/A
- CISO N/A
- EPS
- INTS N/A
- CISO N/A
- Revenue
- INTS N/A
- CISO $54,633,909.00
- Revenue This Year
- INTS N/A
- CISO $78.76
- Revenue Next Year
- INTS N/A
- CISO N/A
- P/E Ratio
- INTS N/A
- CISO N/A
- Revenue Growth
- INTS N/A
- CISO 34.87
- 52 Week Low
- INTS $1.50
- CISO $0.26
- 52 Week High
- INTS $5.78
- CISO $3.84
- Technical
- Relative Strength Index (RSI)
- INTS 53.36
- CISO 50.35
- Support Level
- INTS $2.17
- CISO $0.96
- Resistance Level
- INTS $2.43
- CISO $1.10
- Average True Range (ATR)
- INTS 0.20
- CISO 0.14
- MACD
- INTS 0.01
- CISO 0.01
- Stochastic Oscillator
- INTS 73.08
- CISO 54.15
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.